There was no difference in mislocalisation frequency, as defined by either metric, between familial and sporadic AD groups or between C9orf72 mutation‐carrying and non‐C9orf72‐associated FTLD‐TDP A subjects (data not shown). This evidence concerns the gene C9orf72 and Alzheimer disease.